There are some limitations to the present study because SHPT-associated vascular disease is a complex process involving interactions of primary disease, hypercalcemia, hyperphosphatemia, and parathyroid hormone abnormalities (21, 45). The gene discussed is PTH; the disease is hypercalcemia disease.